Search for: [Abstract = "this way excluded part of factors involving in research results. To confirm the diagnosis by all participants medical history, patient examination, clinical measurments, ecg, exercise ecg, coronarography were made. In examined patients percutaneous angioplasty were made \(PTCA\) and biochemical paramets were taken 6 months after succesful coronary angioplasty. 65% of patients with CAD demonstrated symptoms of CCS I a 35% CCS II according to classyfication of Canadian Cardiological Assocation. By 60% patients with CAD confirmed one vessel coronary disease and by 40% patients multi\-vessel disease. Patients were treated with standard farmacological therapy according obligatory guidlines \(aspirin, ACE\- inhibitor, beta\-blocer, statin\). The study protocol was approved by the Jagiellonian University Medical College Ethics Committee and informed consent was obtained from all participants. Venous blood samples were drawn after an overnight fast to measure the level of anti\-hsp60 antibody, high sensitive C\-reactive protein, fibrinogen, leucocytes and anti\-Ch.p. in class IgG and IgA antibodies. The level of anti\-hsp60 and anti\-Ch.p. \; antibodies were measured by, an immunoenzymatic method \(ELISA\), high sensitivity CRP levels were measured using the immunonephelometric method and using modified Klauss method the level of fibrinogen were measured. The level of leucocytes were measured using"]

Number of results: 1